Prostate cancer Board decisions

The Board has remanded the case due to unclear information regarding the Veteran's prostate cancer residuals, specifically voiding and renal dysfunction since January 1, 2021.

The Board has denied the claim of service connection for the cause of the Veteran's death due to a lack of evidence linking his cardiopulmonary failure and prostate cancer with bone metastasis to his military service.

The Veteran's death was not due to a service-connected condition, and he did not meet the eligibility criteria for VA burial benefits as his body was claimed by his family.

The Board denied the Veteran's claims for service connection for type II diabetes mellitus and prostate cancer, both claimed as due to exposure to herbicide agents. The evidence did not support a finding of exposure to herbicide agents during service.

The Veteran's death was caused by metastatic cancer to the liver, but there is no evidence linking his service or exposure to herbicide agents to these conditions.

The Board has dismissed the appeals for service connection of left and right knee disabilities, as well as prostate cancer residuals and ischemic heart disease (IHD), due to the grant of these conditions in a prior rating decision. The Veteran's appeal is therefore moot.

The Board has determined that more development is needed to determine the etiology of the Veteran's right-hand disability and whether it is related to service, including as being caused or aggravated by a service-connected left-hand disability. The case will be remanded for these purposes.

The Board has remanded the case due to inadequate nexus opinion regarding service connection for prostate cancer, specifically related to in-service chemical exposures.

The Board has remanded the claims for service connection due to insufficient evidence regarding the Veteran's exposure to herbicide agents during his active duty in Korea. The Veteran is seeking service connection for prostate cancer and erectile dysfunction, with prostate cancer potentially linked to Agent Orange exposure.

The Board has remanded the case due to incomplete military personnel records and a need for a VA medical opinion regarding the Veteran's prostate cancer, its cause, and whether service-connected conditions contributed to his death.

The Veteran's prostate cancer is rated at 40 percent since May 1, 2018. The Board found that a higher evaluation beyond this level is not warranted.

The Veteran's prostate cancer residuals, including radiation colitis and urinary frequency with erectile dysfunction, are now rated appropriately.,A TDIU is granted effective November 27, 2009.

The Board has granted service connection for prostate cancer and type II diabetes mellitus (DM II) on a presumptive basis due to exposure to herbicide agents during the Veteran's service in Korea.

The Veteran's claim for a higher rating for prostate cancer residuals was denied, and his mental disability was granted a 70% rating but not more. The prostate cancer residuals are rated at the maximum allowed under current criteria.

The Veteran's claim for a rating in excess of 60 percent for residuals of prostate cancer is denied.,The Veteran's claim for service connection for an acquired psychiatric condition secondary to his service-connected prostate cancer disability is remanded.

The Veteran's prostate cancer was denied service connection as it manifested more than one year after separation and is not shown to be causally related to an in-service injury or disease. The claims for psychiatric, heart, cervical spine, low back, bilateral shoulder, elbow, wrist, hip, knee, ankle, and foot disabilities are remanded due to the failure to obtain examinations and opinions concerning their etiology.

The Board has remanded several issues including service connection for migraine headaches, tinnitus, prostate cancer, peptic ulcer disease, and right thumb disability. The effective date of the grant of service connection for migraine headaches remains July 23, 2015.

The Board has decided that further development is necessary before the claims for service connection for diabetes mellitus, ischemic heart disease, and prostate cancer as a result of exposure to herbicide agents can be adjudicated. The VA will need to obtain authorization and request private treatment records from St. Luke's Medical Center, Dr. S.M., Dr. J.T., Dr. C.L., and Dr. J.S. Additionally, efforts should be made to verify whether the USS Intrepid operated within the 12 nautical mile territorial sea of Vietnam during the Veteran's service.

The Veteran's prostate cancer rating was reduced from 100% to 60%, effective November 1, 2017. The Board found that the evidence did not support a higher rating due to lack of active malignancy or local recurrence.

The Veteran's claim for SMC based on the need for aid and attendance or at the housebound rate was denied because his service-connected disabilities do not cause him to be in need of regular aid and assistance. The claim for financial assistance for automobile and adaptive equipment was also denied as he does not meet the criteria due to nonservice-connected disabilities causing his need.